2-bromo-N-1,3-thiazol-2-ylacetamide, 95+%, 250mg

5-bromo-4-methyl-1H-1,2,3-triazole, 97, 1g

Methyl (E)-3-(2-fluorophenyl)prop-2-enoate, 95.0%, 25g

(T-4)-[[2,2'-[(1S,2S)-1,2-Cyclohexanediylbis[(nitrilo-κN)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato-κO]](2-)]zinc, 95%, 25g

3-tert-Butylisoxazol-5-amine, 97.0%, 25g

5-Amino-2-bromo-3-fluoropyridine, 95.0%, 5g

Benzoic acid, 5-(aminosulfonyl)-2-chloro-, 95%, 10g

Barium Chloranilate Trihydrate>97.0%(T)25g

2-(2-ETHYL-2H-TETRAZOL-5-YL)ANILINE, 90.0%, 250mg

METHYL 2-BROMO-4-FLUORO-6-METHYLBENZOATE, 95.0%, 100mg

anti-GFP-tag mouse monoclonal, F56-6A1.2.3, 25 µg

4-CYCLOPROPYL-2-FLUORO-6-METHYLBENZAMIDE, 95.0%, 250mg

2-(4-methylphenyl)-1H-indene-1,3(2H)-dione, 95.0%, 1g